首頁 > 市場調查報告書 > 醫療設備

生技設備

微生物定序服務市場規模、佔有率和成長分析（按技術、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898116

微生物定序服務市場規模、佔有率和成長分析（按技術、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Microbiome Sequencing Services Market Size, Share, and Growth Analysis, By Technology (Sequencing By Synthesis, Sequencing By Ligation), By Application (Shotgun Sequencing, RNA Sequencing), By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，微生物組定序服務市場規模將達到 17 億美元，到 2025 年將達到 18.9 億美元，到 2033 年將達到 42.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 10.7%。

由於基因技術的進步以及人們對微生物組在人類健康中所扮演角色的認知不斷加深，微生物組定序服務市場正經歷顯著成長。這激發了人們對個人化醫療的興趣。越來越多的研究將微生物組與健康狀況聯繫起來，從而推動了消費者對人體微生物群落資訊的需求。因此，微生物組分析正成為治療策略的重要組成部分，尤其是在新型微生物組標靶治療方法不斷出現的情況下。將微生物組定序與轉錄組學和代謝體學相結合的多體學學方法，正在增強研究能力，並揭示人類與細菌之間複雜的相互關係。此外，這個不斷擴展的領域致力於利用先進的定序技術來揭示疾病關聯，從而為更早、更準確的診斷鋪平道路。微生物組定序的應用範圍也在環境和農業研究領域不斷擴大，進一步展現了其多功能性。

微生物組定序服務市場促進因素

微生物組定序服務市場的擴張主要得益於人們對個人化醫療日益成長的關注。隨著醫療保健不斷向個人化治療策略發展，微生物組分析透過提供每位患者體內微生物組成的具體訊息，發揮關鍵作用。這些寶貴的資訊能夠提高診斷準確性和疾病管理效果，從而推動對個人化解決方案的需求不斷成長。因此，醫療保健領域對微生物組分析的日益普及正在推動市場成長。這表明，微生物組分析在實現最佳患者療效以及促進醫學研究和治療應用創新方面發揮著至關重要的作用。

微生物組定序服務市場限制因素

微生物組定序服務市場面臨的一大挑戰是相關技術的成本。儘管該領域已取得顯著進展，但定序設備、試劑和分析流程帶來的經濟負擔仍可能成為小規模研究機構和診所的障礙。高成本可能會抑制它們有效採用和利用這些服務的能力，從而限制整體市場成長潛力。因此，微生物組定序服務的可負擔性仍然是一個關鍵障礙，必須加以解決，才能促進這一快速成長的研究領域的更廣泛應用和進一步發展。

微生物組定序服務市場趨勢

微生物組定序服務市場正呈現出人工智慧 (AI) 和機器學習技術日益融合的顯著趨勢。這一發展趨勢增強了對複雜微生物組數據的分析和解讀能力，從而能夠更精準地洞察微生物功能及其對健康和疾病預防的重要影響。透過簡化數據處理流程並提升預測能力，人工智慧驅動的解決方案有助於制定個人化的健康策略和治療性介入。對可靠且先進的微生物組分析工具的需求正在推動市場成長，而人工智慧則被視為加深我們對微生物組在人類健康中所扮演角色理解的關鍵推動因素。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較
主要企業簡介
- Charles River Laboratories
- Eurofins Scientific
- BGI
- Microbiome Insights Inc.
- MR DNA
- Baseclear BV
- Clinical Microbiomics AS
- Zymo Research
- Rancho Biosciences
- Metabiomics
- CosmosID
- ZIFO
- Shanghai Realbio Technology（RBT）Co., Ltd.
- Second Genome

結論與建議

簡介目錄

Product Code: SQMIG35J2091

Microbiome Sequencing Services Market size was valued at USD 1.7 Billion in 2024 and is poised to grow from USD 1.89 Billion in 2025 to USD 4.26 Billion by 2033, growing at a CAGR of 10.7% during the forecast period (2026-2033).

The microbiome sequencing services market is experiencing significant growth driven by advancements in genetic technology and a heightened understanding of the microbiome's role in human health, fostering interest in personalized medicine. Research linking the microbiome to health outcomes is increasing consumer demand for insights into the microbial communities within the body. Consequently, microbiome analysis is becoming integral to treatment strategies, particularly as new microbiome-targeted therapies emerge. The integration of multi-omics approaches, combining microbiome sequencing with transcriptomics and metabolomics, enhances research capabilities and emphasizes the intricate relationship between humans and bacteria. Furthermore, this expanding field focuses on utilizing advanced sequencing techniques for disease association, paving the way for earlier and more accurate diagnoses. Applications extend into environmental and agricultural studies, underscoring the versatility of microbiome sequencing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microbiome Sequencing Services Market Segments Analysis

Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microbiome Sequencing Services Market

The expansion of the microbiome sequencing services market is significantly influenced by the growing emphasis on personalized medicine. As healthcare continues to shift towards individualized treatment strategies, microbiome analysis plays a crucial role by delivering specific insights into the composition of microorganisms present in each patient. This valuable information enhances the accuracy of diagnoses and the effectiveness of condition management, contributing to a rising demand for tailored solutions. Consequently, the integration of microbiome analysis into healthcare practices is driving the market forward, highlighting its importance in achieving optimal patient outcomes and fostering innovation in medical research and therapeutic applications.

Restraints in the Microbiome Sequencing Services Market

A notable challenge facing the microbiome sequencing services market is the expense associated with these technologies. Despite considerable advancements in the field, the financial burden linked to sequencing equipment, reagents, and analytical processes can be prohibitive for smaller research institutions and clinics. This high cost can hinder their ability to adopt and utilize these services effectively, subsequently limiting the market's overall growth potential. Consequently, the affordability of microbiome sequencing services remains a critical barrier that must be addressed to facilitate broader access and encourage further development in this burgeoning area of research.

Market Trends of the Microbiome Sequencing Services Market

The microbiome sequencing services market is witnessing a notable trend characterized by the rising integration of Artificial Intelligence (AI) and machine learning technologies. This evolution enhances the analysis and interpretation of complex microbiome data, allowing for more precise insights into microbial functions and their substantial influences on health and disease prevention. As AI-driven solutions streamline data processing and improve predictive capabilities, they facilitate the development of personalized health strategies and therapeutic interventions. The demand for reliable and sophisticated microbiome analysis tools is driving market growth, positioning AI as a pivotal component in advancing our understanding of the microbiome's role in human health.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Microbiome Sequencing Services Market Size by Service & CAGR (2026-2033)

Market Overview
Sample Preparation
Sequencing and Library Preparation
Data Analysis

Global Microbiome Sequencing Services Market Size by Technology & CAGR (2026-2033)

Market Overview
Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Pyrosequencing
Sanger Sequencing
Others

Global Microbiome Sequencing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Shotgun Sequencing
Targeted Gene Sequencing
RNA Sequencing
Whole Genome Sequencing
Others

Global Microbiome Sequencing Services Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Clinics
Others

Global Microbiome Sequencing Services Market Size & CAGR (2026-2033)

North America, (Service, Technology, Application, End User)
- US
- Canada
Europe, (Service, Technology, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Service, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Service, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Service, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbiome Insights Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR DNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baseclear BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Microbiomics AS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymo Research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rancho Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CosmosID
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZIFO
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Realbio Technology (RBT) Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Second Genome
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments